Gufic Biosciences Limited — Important, 22-11-2024: General Updates

The BSE and NSE have imposed fines of ₹1.72 lakh each on Gufic Biosciences for alleged non-compliance with Regulation 17(1A) regarding the appointment of Mr. Kamal Kishore Seth as an Independent Director, who is over 75 years of age, without a prior special resolution from shareholders. This fine follows a previous penalty imposed for the same issue. Gufic maintains that the applicable regulations do not explicitly require a special resolution to precede the appointment and are actively pursuing a waiver for the fines imposed, arguing that the non-compliance stems from differing interpretations of the rules. The company successfully regularized Mr. Seth’s appointment at its recent AGM, which could mitigate future penalties. Investors should monitor the situation closely, as the resolution of this issue may influence the company's compliance reputation and operational autonomy.